Lon Cardon

Lon Ray Cardon FMedSci is an American statistical geneticist who is Chief Scientific Officer at BioMarin Pharmaceutical. Before joining BioMarin in 2017, he had conducted research on the genetic basis of human diseases for over twenty-five years. He had previously served as a full professor at the University of Oxford in the United Kingdom, and at the University of Washington and Fred Hutchinson Cancer Research Center in the United States. He subsequently entered the pharmaceutical industry as a senior vice president at GlaxoSmithKline. In this industry, he has attempted to translate the results of genetic research regarding the causes of human diseases into improved medical treatments.[2][3] He was elected to the Academy of Medical Sciences in 2005. He is also a fellow of the American Association for the Advancement of Science[2] and a former Wellcome Trust Principal Research Fellow.[3]

Lon R. Cardon FMedSci
Born	Lon Ray Cardon
Nationality	United States
Education	University of Puget Sound University of Colorado at Boulder[1]
Awards	Wellcome Trust Principal Research Fellow
Scientific career
Fields	Medical genetics Statistical genetics
Institutions	BioMarin Pharmaceutical Fred Hutchinson Cancer Research Center GlaxoSmithKline University of Oxford University of Washington
Thesis	Multivariate path analysis of specific cognitive abilities in the Colorado Adoption Project (1992)
Doctoral advisor	David W. Fulker
Doctoral students	Gonçalo Abecasis

References

1. "Frontiers in Population Genomics Research Meeting: Participants". National Human Genome Research Institute (NHGRI). Retrieved 2 March 2019.
2. "Lon Cardon". All of Us Research Program. Retrieved 2 March 2019.
3. "Professor Lon Cardon". The Academy of Medical Sciences. Retrieved 2 March 2019.

External links

• Biography at the National Institutes of Health's All of Us Research Program
• Lon Cardon publications indexed by Google Scholar